BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
65.36
-0.81 (-1.22%)
At close: Mar 6, 2026, 4:00 PM EST
64.99
-0.37 (-0.57%)
After-hours: Mar 6, 2026, 6:36 PM EST
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $12.67 billion as of March 6, 2026. Its market cap has increased by 81.02% in one year.
Market Cap
12.67B
Enterprise Value
13.95B
1-Year Change
81.02%
Ranking
Category
Stock Price
$65.36
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $12.67B, an increase of 281.68%. That is a compound annual growth rate of 22.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 16.89B |
| Ascendis Pharma | 14.57B |
| Ionis Pharmaceuticals | 12.42B |
| BioMarin Pharmaceutical | 11.65B |
| Summit Therapeutics | 11.58B |
| Jazz Pharmaceuticals | 11.30B |
| Exelixis | 10.72B |
| Madrigal Pharmaceuticals | 10.08B |